Clinical Trials Browser

Withdrawn × Hydroxychloroquine × Breast × Clear all

NCT05689359 2024-03-08

Evaluation of Hydroxychloroquine to Prevent CIPN

Phase 2 Withdrawn

Breast Neoplasms, Peripheral Nervous System Diseases

NCT04316169 2022-12-23

Hydroxychloroquine, Abemaciclib and Endocrine Therapy in Hormone Receptor Positive (HR+)/Her 2 Negative Breast Cancer

Phase 1 Withdrawn

BreastOther solid neoplasm

Solid Tumor

NCT03400254 2020-04-28

GLACIER

Phase 1/2 Withdrawn

Breast Neoplasms